T1	intervention 0 9	Tamoxifen
T2	control 219 226	placebo
T3	eligibility 230 278	women who are at increased risk of breast cancer
T4	No-of-participants 284 287	488
T5	duration 552 558	5-year
T6	outcome-Measure 601 608	anxiety
T7	outcome-Measure 610 632	psychological distress
T8	outcome-Measure 638 656	sexual functioning
T9	outcome 1181 1199	vasomotor symptoms
T10	outcome 1262 1313	low energy, breast sensitivity, and visual blurring
T11	outcome 971 1019	changes in anxiety, mood, and sexual functioning
